Tradestie Institutional Equity Comparison Engine

PIII vs STLN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PIII Overall Edge

PIII Captures Institutional Edge (1โ€“1 Pillars ยท 6โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to P3 Health Partners Inc. Common Stock (PIII) driven by superior Growth & Margin while STLN counters with relative strength in Momentum & Technical. Fundamentally, PIII trades at N/M Forward P/E with -5.2% operating margin (+14.8% YoY revenue) versus STLN at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, PIII sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against STLN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
PIII N/M vs STLN N/M Fwd P/E
Growth & Margin Winner PIII
Op Margin -5.2% vs N/A ยท YoY +14.8% vs N/A
Momentum & Technical Winner STLN
1Y -71.7% vs -42.0% ยท 52W Pos 1% vs 1%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
PIII NASDAQ
P3 Health Partners Inc. Common Stock
Services-Health Services
$1.69
-9.14% 1D
Market Cap $385.5M
1M Return -61.24%
1Y Return -71.74%
Forward P/E N/M
Unified AI Score
38.6 / 100 SELL
Tech 25.0 Fund 40.0 Flow 50.0 Mom 49.0
STLN US Equity
STLN
Institutional Equity
$3.00
-5.66% 1D
Market Cap N/A
1M Return -56.58%
1Y Return -41.97%
Forward P/E N/M
Unified AI Score
46.6 / 100 HOLD
Tech 45.0 Fund 46.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PIII -71.74% STLN -41.97% Spread: +41.75 pp (STLN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PIII TTM Op. Margin: -5.2% STLN TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PIII vs STLN. Trailing 12-month operating profitability (PIII -5.2% vs STLN N/A) and valuation multiples (PIII N/M vs STLN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PIII (6) vs STLN (1)
Institutional Metric PIII STLN Criterion Row Winner
Market Capitalization Scale $385.5M N/A Larger Scale PIII
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +14.8% N/A Higher Growth PIII
Operating Margin (TTM) Profitability -5.2% N/A Higher Margin PIII
Net Profit Margin Profitability -3.3% N/A Higher Margin PIII
Return on Equity (ROE) Capital Efficiency -105.8% N/A Higher ROE PIII
52-Week Range Position Momentum 1% ($2โ€“$17) 1% ($3โ€“$7) Stronger Trend Tie
Beta / 30D Volatility Risk Regime -0.87ฮฒ ยท 132% Vol 1.42ฮฒ ยท 175% Vol Lower Realized Risk PIII
Unified Institutional Score Composite Signal 38.6 / 100 (SELL) 46.6 / 100 (HOLD) Higher Composite STLN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PIII vs STLN Buy Guide
PIII UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PIII Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
STLN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live STLN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PIII nor STLN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.